Doctors in the UK are expected to practice in line with evidence-based guidelines, but they must consider individual patient circumstances, local resources, and the specific guidance from their respective health systems
NICE guidance recommends regular monitoring of patients on GLP-1 receptor agonists, including assessment of gastrointestinal tolerability, weight changes, and glycaemic control
noted that although gastrointestinal issues have been related to GLP-1 antagonist use, they consider a diagnosis of gastroparesis to be unusual. Hyposalivation Research has found that semaglutide can cause secondary xerostomia, otherwise known as dry mouth (19)
Eptifibatide is small, fast-acting, injectable, geared toward short interventions
Vial-size math reference table This is the table to scan if you have a specific vial size and want to know how much water to add and what your dose will look like on a U-100 syringe